Biocon's Semglee, an insulin glargine injection, gets US FDA approval

The Bengaluru-headquartered company also commits to provide affordable insulin at Rs 7 per day to lower and middle income countries as compared to Rs 350 per day currently

from Companies https://ift.tt/2UCa3hP